多肽CRDMO平台
目录肽
中肽生化目录肽版块全新呈现，致力于打造全球最全面的多肽供应平台！我们专业的学术团队将时刻追踪最新最热的研究动向，帮助您发现实际需求，并以最高质量标准提供您所需要的产品。我们将我们将不定期更新产品列表，为您最大限度地节约科研时间，敬请广大客户朋友关注！
MART-001B
MART-1 (26-35) (human)
Glu-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val\nTrifluoroacetate salt
Glu-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val\nTrifluoroacetate salt
Size：5
P1(RMB)：3000
MW：943.11
One letter sequence：EAAGIGILTV
Molecular Formula：C42H74N10O14
Description：MART-1 (26-35) has been shown to be better recognized by a number of polyclonal and monoclonal populations of tumor-reactive HLA-A*0201-restricted cytotoxic T lymphocytes (CTL) than MART-1 (27-35) (human)
Literature Reference：A.van Elsas et al., Eur. J. Immunol., 26, 1683 (1996)\nP.Romero et al., J. Immunol., 159, 2366 (1997)\nD.Valmori et al., J. Immunol., 160, 1750 (1998)\nQ.Chen et al., Cancer Immunol. Immunother., 47, 191 (1998)\nK.S.Lang et al., J. Invest. Dermatol., 116, 891 (2001)
Cas：156251-01-3
P1(RMB)：3000
MW：943.11
One letter sequence：EAAGIGILTV
Molecular Formula：C42H74N10O14
Description：MART-1 (26-35) has been shown to be better recognized by a number of polyclonal and monoclonal populations of tumor-reactive HLA-A*0201-restricted cytotoxic T lymphocytes (CTL) than MART-1 (27-35) (human)
Literature Reference：A.van Elsas et al., Eur. J. Immunol., 26, 1683 (1996)\nP.Romero et al., J. Immunol., 159, 2366 (1997)\nD.Valmori et al., J. Immunol., 160, 1750 (1998)\nQ.Chen et al., Cancer Immunol. Immunother., 47, 191 (1998)\nK.S.Lang et al., J. Invest. Dermatol., 116, 891 (2001)
Cas：156251-01-3
